Answers are grounded in this paper and cite their sources.
Metabolic reprogramming links to post-MI inflammation and fibrosis; leaves open whether targeting these pathways alters HF progression.
Myocardial infarction (MI) is a metabolic disorder that poses a notable threat to human health, with post-MI heart failure (HF) markedly affecting patient prognosis. The overactivation of inflammation and fibrosis serves an important role in the progression of post-MI HF; however, the underlying mechanisms remain poorly understood. The present study aimed to investigate the associations among metabolic reprogramming, inflammation and fibrosis after MI. By integrating single-nucleus RNA sequencing and spatial transcriptomics data from MI and dilated cardiomyopathy, a common metabolic feature, glycolysis, was identified. This feature was shared by cardiomyocytes and monocytes in myocardial infarction and was specifically localized to the peri-infarct region. Pyruvate dehydrogenase kinase 4 was identified as a core gene linking metabolic reprogramming to fibrosis. A mouse model of MI was established by permanent ligation of the left anterior descending coronary artery. PDK4 knockout was applied to evaluate its role in post-infarction fibrotic remodeling. Furthermore, the results of the present study revealed a cross-cellular metabolic reprogramming process mediating chronic inflammatory cell interactions. In conclusion, the findings of the present study suggested that targeting metabolic reprogramming may offer a promising strategy for preventing inflammation and fibrosis to mitigate post-MI HF.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: